shRNA molecule silencing DNAPK radiosensitizer (Johns Hopkins University)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameshRNA molecule silencing DNAPK radiosensitizer (Johns Hopkins University)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer

Mechanisms of ActionDNA-dependent protein kinase inhibitors

TargetsDNA-dependent protein kinase

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohns Hopkins University School Of Medicine

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A